chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fatigued; Muscle pains in my legs/muscle pain all over body; Achy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of   in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 28-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Information has been received from a registered nurse concerning a 17 year old female patient with a drug allergy to erythromycin and no medical history, who on 21-FEB-2007 was vaccinated IM with a 0.5ml first dose of Gardasil (Lot# 655324/0089U). There was no concomitant medication. On 25-APR-2007 the patient received her second dose of the vaccine while pregnant (LMP 28-MAR-2007). On 16-MAY-2007, the patient experienced an uncomplicated spontaneous miscarriage. Unspecified medical attention was sought. It was reported that the patient has not required any treatment and has not experienced any further problems. Laboratory diagnostic studies included a quantitative HCG. At the time of this report, the patient was recovering. No product complaint was involved. Upon internal review, uncomplicated spontaneous miscarriage was considered to be an other important medical event. Additional information has been requested.
Significant lymphadenopathy noted on left cervical nodes and clavicular nodes. First noticed about 10 days after vaccine given. Has persisted.
12 hours past injection: fever and chills 18 hours past injection: left armpit begins to swell, no pain, squishy  42 hours past injection: left armpit fully swollen, painful, firm to touch
No adverse drug reaction.  The wrong drug was given to the patient.  The patient was supposed to receive Pneumococcal polysaccharide and pneumococcal conjugate was ordered incorrectly. There is no need to re-administer an additional vaccine and that adverse effects (caused by the incorrect vaccine) are not expected.
Swelling (7x5 cm), erythema almost like urticaria and mild itching at injection site.
FOUR INCH RED AND HOT LUMP AT INJECTION SITE; COULD NOT DO YOGA / TROUBLE WITH STAIRS; LEG HURTED; FOUR INCH RED AND HOT LUMP AT INJECTION SITE; QUEASY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient is needle phobic. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced four inch red and hot lump at injection site, could not do yoga / trouble with stairs, leg hurted, four inch red and hot lump at injection site, and queasy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the four inch red and hot lump at injection site, queasy, leg hurted, four inch red and hot lump at injection site and could not do yoga / trouble with stairs was not reported. This report was non-serious.
On May 24th developed fullness in Left ear, this was on/off for 2 weeks. On June 9 developed vertigo, on may 10th developed left sided Bell's Palsy.
After the usual signs of pain in my arm and sickness the next couple days, I was starting to get my period and I could tell things were different.  I had early spotting, and it was stretched out for longer days. I normally have spotting one day, a bad day or two or bleeding, then done. But I was having many days of spotting before I would bleed, which is weird for me. Also, my periods got way more painful, and still are more painful. The past 6 months I've had the most painful periods of my life. Lastly, I still get phantom arm pain where the needle was, which is super strange to me. It will feel like I got my shot yesterday sometimes, even though it's been months.
This spontaneous report as received from a nurse refers to a patient of unknown age. The patient was subcutaneously vaccinated with lot # (667741/0811Z), Exp Date(10-JUN-2012), 0.5 ml MMR II (dose number was unspecified) on 19-JUL-2012, No other co-suspects were reported. No concomitant medications were reported. It was reported that on 19-JUL-2012 the patient was inadvertently administered MMR II that had expired on 10-JUN-2012. No adverse effects reported. It was unspecified whether the patient had sought medical attention or not. The outcome were unknown. This is one of several reports received from the same source. Additional information is not expected
How long do side effects last before I should be worried; My side effect of weakness in my legs lasted about 5 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (How long do side effects last before I should be worried) and MUSCULAR WEAKNESS (My side effect of weakness in my legs lasted about 5 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (How long do side effects last before I should be worried) and MUSCULAR WEAKNESS (My side effect of weakness in my legs lasted about 5 days). At the time of the report, VACCINATION COMPLICATION (How long do side effects last before I should be worried) and MUSCULAR WEAKNESS (My side effect of weakness in my legs lasted about 5 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up received on 30-jun-2021 contains significant information. Added New event: Weakness of lower extremities added. Outcome of the event updated.
My son started to develop a high fever, which I related to teething. However on day 10 of getting the shot, he woke up with red bumps on his face. By that afternoon his entire body was covered in them. We took him to the urgent care where they gave him an epi shot (not knowing what he was having an allergic reaction to). His heart rate was very high as well. They monitored him for a bit, then advised us to come back the next day to follow up. As the night went on, we noticed that the red bumps were getting redder and more of them. The next morning we took him back to urgent care for follow up. The dr then gave him another epi shot and sent us to the hospital. That afternoon around 4pm, the ER dr said that he was having a reaction to the MMR shot. They hooked him up to IV for fluids, gave him prednisone, and monitored him for a few hours. On Monday Aug 20th, we went to see our GP, where he did say that yes he believed he was having a reaction to the MMR vaccine. Today is now Tuesday the 21st, he is still covered in bumps, however the redness of the bumps is fading.
I had vomiting, dizziness, diarhhea, hot shivers, rashy-redness in arm near site of injection, almost down to elbow. The shivers started first, the rest peaked about 3:00am.
I was having some general dry sink on hair. I went to a dermatologist about it and they said that is was folliculitis. I had sores, inflammation, and irritation of my hair. This has been going on for about a year now. I am continuedly on antibiotics and it is helping a little bit.
Patient received vaccine on 5/24/21. He called pharmacy on 6/14 complaining that his arm had been sore for about a week since getting the vaccine. he stated that his arm did not bother him after he got the vaccine but started "aching" on 6/7/21 and has been aching on and off every since. patient states that he does not have problem moving his arm or raising arm above his head, but was concerned that the pain did not start until approximately 2 weeks after receving vaccine. he states that there is no redness or swelling or heat around the injection site, has not developed rash or any other reactions, etc. I told patient to continue taking tylenol since that was helping with his muscle soreness and to contact his doctor if aching sensation continued.
Moderna vaccine dose 1:  10 days later,  at the injection site -the area around the injection side feels hard, it has turned red and it itches.  This did not happen until day 10.  I put cortizone on it to stop the itching which helped some  but it still itches.
Right upper arm red and swollen. Area approximately 11.5 by 11.5 cm with irregular edges.
10mins post vaccination, pt had a syncopal event w/ associated nausea.   Vitals: 98/54, 77, 12 Vitals stable.  No emesis.  Pt laid down, drank water and nausea improved. Mother reported that the pt was sick, including cough, that day and did not go to school (not reported prior to administration).  Mother also reported that the pt was very anxious and has had a hx of nausea w/ anxiety.  Pt stayed for an additional 10 min for observation and was released in stable condition.
Within 10 minutes after vaccinated I experienced slow heart beat, unable to move all limbs, unable to talk except "what's happening" 2 hours after vaccinated. Weak, dizzy, blurred vision. This all lasted 2 hours and 15 minutes then I mustered all my energy to drive home then resumed my paralysis.
LEFT DELTOID BECAME SWOLLEN, RED AND TENDER AFTER VACCINATION.  PARENT NOTICED SYMPTOMS AT APPROXIMATELY 9:30PM ON DAY OF VACCINATION.  CHILD BROUGHT INTO CLINIC TODAY (DAY AFTER VACCINES)- AREA CONTINUES TO BE RED, SWOLLEN AND TENDER MORE THAN 12 HOURS AFTER BEING DETECTED BY PARENTS.
Patient is pregnant; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant) in a 35-year-old female patient (gravida 4, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     The patient's past medical history included Melanoma in October 2013 and Spontaneous abortion on 24-Nov-2018. Concomitant products included DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS) for Nausea, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 12-Nov-2020 and the estimated date of delivery was 19-Aug-2021. On 23-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixth week of the pregnancy.  On 23-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Dec-2020, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This is a case of product exposure during pregnancy with no associated AE's for this 35 year old female. Patient will continue to be contacted for further monitoring of AE's during the pregnancy.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AE's for this 35 year old female. Patient will continue to be contacted for further monitoring of AE's during the pregnancy.
Discharge Provider:  DO  Primary Care Physician at Discharge: MD Admission Date: 9/1/2022  Discharge Date: 09/02/2022  DETAILS OF HOSPITAL STAY: Seizure    HOSPITAL COURSE: Patient is a 16 y.o. female Patient has a history of global developmental delay, ADHD, Autism, Epilepsy, Anxiety, mild OSA (without CPAP), and intermittent explosive disorder had been transferred from ER for increased frequency of seizure and COVID-19 positive. Patient had 8 episodes of grand mal seizures in a day prior to arrival to our hospital. Had COVID-19 sick contacts at home for the past 2 weeks, tested positive for Covid-19 on 8/31/22 at the outside hospital.    Her labs were concerning for WBC of 15.9 and COVID 19, Respiratory panel otherwise negative. Outside hospital CXR on 8/31/22 with suboptimal inspiration, peripheral opacities in the left mid and lower lung may reflect combination of soft tissue chest wall opacity vs atelectasis.    Patient had no other episodes of seizures during her admission here. Per neurology, she was started on Valium bridge on 9/1/22, 2.5 mg TID for 3 days, then 2.5 mg BID for 3 days, then 2.5 mg qD for 3 days. She was started on Remdesivir on 9/1/22 but disconnected her own IV. She was started Paxlovid on 9/1/22, given that her admission was not for COVID but instead for her seizures. She had no hypoxia during her stay. Her guanfacine dose was halved while on Paxlovid for the next 4 days.     Otherwise patient had stable vital signs and did well during her admission
Information has been received from a nurse practitioner concerning a patient who was on an unspecified date was vaccinated with PNEUMOVAX 23. The nurse practitioner reported that on an unspecified date, "within a couple of hour after administration of PNEUMOVAX 23" the patient's arm became painful on the upper side and it was a little red. The patient sought medical attention with the nurse practitioner. The patient's symptoms lasted for 3 days but the patient did not require treatment. Follow up information has been received from a nurse practitioner regarding the 65 year old female patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23. The nurse practitioner contacted during the telephone follow-up call could not supply the patient's date of birth, date of vaccination, lot number or date of the event. Follow up information has been received from the nurse practitioner who reported that it was determined that the arm became painful on the upper side and the arm was a little red was no adverse event and that was merely a localized reaction to the PNEUMOVAX 23. Additional information is not expected.
Hallucinations started 4 hours after shot.  Drug use was considered.  hallucinations increased over time, drug use still suspected.... eventuatlly she tried to stab her mother and broke into someones house and assualted a man. She was placed to "detox" in jail and that hasnt happened.  She is still out of it... if not worse than the day she got arrested. When i sat down to timeline the events i realized the booster happend right before this all started.
On 9/15/2021 I woke up very dizzy. For 4 hours I was cold and clammy and weak. My fingers and toes tingled. Later that day I had nausea and vomiting. When I was cold and clammy I felt distant or far away. I called my doctor and she prescribed Meclazine for the dizziness, which I never took. I was dizzy for several days after 9/15. I did not visit my doctor because they were limiting visits due to the covid pandemic.
Information was received on 20-MAR-2017 from a lawyer regarding a case in litigation. It is alleged in litigation that a female (age not reported) in 2015, was inoculated with the ZOSTAVAX (dose, route of administration, site of administration, lot number, expiration date were not reported) for the prevention of shingles as part of a routine adult medical examination. The vaccine was recommended and administered by the female patient's primary care physician. Prior to receiving the ZOSTAVAX vaccine, the female had never suffered from or been diagnosed with herpes zoster, or any other ailment collectively referred to as "shingles." As a direct result of the vaccine, the patient suffered, is suffering and/or will continue to suffer from mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, she suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. On or about 14-JUN-2016, the female patient returned to her primary care provider. The patient addressed symptoms of a painful rash to her primary care physician, who identified the ailment as shingles on the patient's right flank. The patient was prescribed VALTREX, gabapentin, and acyclovir as directed for treatment of the patient's ongoing herpes zoster outbreak. As a direct and proximate consequence of ZOSTAVAX, patient sustained serious personal injuries and related losses including, but not limited to, mental anguish, physical pain and suffering, diminished capacity for the enjoyment of life, a diminished quality of life, medical and related expenses, and other losses and damages. The events of shingles on the right flank and emotional distress were considered disabling. Additional information has been requested.
Severe chest pains, heart populations. Edema in lungs. Blood pressure issues. Pleurisy
Suspected vaccination failure; Bouts of shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  The patient's past medical history included shingles (got since the patient was in early 20s).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient was a couple of years shy of the big 60.  The patient had been going through bouts of shingles ever since in my early 20's.  After receiving Shingles vaccine, the patient got shingles. The patient stated that, thank goodness for cell phones, he/she could take a picture, so his/her unbelieving doctor could finally push through w a test.  He/she also stated that, the Shingles shot was good for reducing symptoms by 80 percent. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Pt awoke at 1 AM, about 30 hr after vaccination, with hives, diarrhea, vomiting, shortness of breath, lip swelling, and wheezing. Given Epipen and Benadryl at home, taken by ambulance to ED, had Epipen, Benadryl, prednisone and Zantac. Admitted to hospital for 2 days.
Itchy red dots near injection site; red dots; This case was reported by a nurse via call center representative and described the occurrence of itchy rash in a 85-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th November 2019, the patient received the 2nd dose of Shingrix. On 9th November 2019, less than a day after receiving Shingrix, the patient experienced itchy rash and red rash. The patient was treated with non-drug therapy (Ice Pack (No Medication)). On an unknown date, the outcome of the itchy rash was not recovered/not resolved and the outcome of the red rash was unknown.   It was unknown if the reporter considered the itchy rash and red rash to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix and had itchy, red dots near the injection site. The patient has attempted to treat the symptoms at home with ice and movement, but symptoms are ongoing. The reporter consented to follow up. The batch number and additional details not available at the time of this call, but nurse consents to follow up from safety.
Fever; This case was reported by a consumer and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per vaccine indication. The patient experienced fever with Shingrix. The patient prefered not to give information.
I woke up Wednesday morning with a sore throat I could barely swollen then I had headache, cough, body aches, and started feeling bad. It was so bad that I lost weight. I tested for COVID-19 the same day but it was negative. I tested again on Thursday I was still negative but I still had the same symptoms. Then, Friday when I spoke to my doctor I tested positive and he prescribed me PAXLOVID. This was the worse part to me because I got so sick. I still have a little cough.
Got a rash on upper arms, thighs and chest it was very itchy which lasted for 2 months then went away and came back. Still have flare ups
Noted dizziness night of injection followed by fatigue the next 2 days. On third day (2/25/2019) noted red raised blotchy rash from the neck down to waist sparring the extremities with pruritis. No vesicles.  No shortness of breath or swelling. Pt relates reaction is similar to that experienced with her other drug allergies. Advised by PCP to use benadryl and to not get the second in series of SHINGRIX over the next 2-6 mths. Of note pt relates a new medication to treat chronic migraines (ajovy) of which she had her first injection on 02/07/2019). As of this writing, rash has spread somewhat to scalp. Feels benadryl is helping. Has received no other vaccines previous month.
I went through Menopause and hadn?t had a hot flash or night sweats in over 8 months.  After getting the booster on 1/19/22, they started up again a few days later.  I?m getting them almost daily and nightly.  Worse than when I went through it the first time.
This spontaneous prospective pregnancy report was received from a registered nurse referring to her daughter of unknown age. Nurse reported that her daughter had allergies to BACTRIM, CECLOR, SUPRAX and azithromycin caused rash; and vancomycin caused rash and swelling of the lips. In December 2014, the patient was vaccinated with an unspecified dose of VARIVAX (Merck) (lot # not reported). No pertinent medical history was reported. There was no concomitant medication. The patient became pregnant with approximately LMP of 16-DEC-2014 and approximately EDD of 22-SEP-2015. The nurse reported that after vaccination it was discovered, by serum pregnancy test and prolactin level, that the patient was at the time of reporting pregnant, 6 to 7 weeks gestation. No adverse effects were reported. No treatment was given for the adverse events. The pregnancy outcome was pending. The patient did not seek medical attention. Additional information is not expected.